RxDoctor Payments Data

Beth Devine

Family · Providence, KYNPI 1679670202

Payments from drug & device makers

$5,978in general payments, 2019–2025

Across 316 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Corium, LLC$672
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$582
  • Otsuka America Pharmaceutical, Inc.$553
  • Vanda Pharmaceuticals Inc.$368
  • Supernus Pharmaceuticals, Inc.$342
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$5,84398%
  • Education$591%
  • Other$761%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,978 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$101,443
VraylarCariprazine Hcl57$97,882
RexultiBrexpiprazole27$43,991
FanaptIloperidone13$29,612
Lurasidone Hcl33$5,055
Atomoxetine Hcl42$4,760
Asenapine Maleate13$2,461
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen81$1,257
Buspirone Hcl79$1,203
Zolpidem Tartrate ErZolpidem Tartrate19$1,095
Oxcarbazepine21$862
Aripiprazole24$681
Bupropion XlBupropion Hcl40$520
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$493
Trazodone Hcl36$428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$16$101,44312 claims
AbbVieVraylar$1,486$97,88257 claims
Otsuka America Pharmaceutical, Inc.Rexulti$553$43,99127 claims
Vanda Pharmaceuticals Inc.Fanapt$368$29,61213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.

Other family in Providence

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →